2017 EMA Veterinary Medicines Info Day Organised in collaboration with IFAH-Europe

‘The latest developments' in scientific review, regulation and marketing authorisation procedures 16-17 March 2017, European Medicines Agency (EMA), London Final Programme Thursday 16th March 2017 13:30

Registration opens

14:00

Introduction and welcome

Session I: Scientific developments 14:10

Chair: Rick Clayton (IFAH-Europe)

CVMP achievements 2016: Highlights and reflections (30’) David Murphy (Chair of CVMP)

14:40

Anthelmintic resistance: Status including feedback from the focus group meeting 13 June 2016 and presentation on the CVMP Reflection paper (20’) Gesine Hahn (EU expert, Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

15:00

Antimicrobial resistance (AMR): Presentation on the joint EMA/EFSA RONAFA opinion; harmonisation of SPCs of antimicrobial veterinary medicines under current legislation (20’) Helen Jukes (Chair of CVMP Antimicrobials working party)

15:20

Recent developments in environmental assessment (20’) Chris van den Eede (Zoetis/IFAH-Europe)

15:40

Questions (20’)

16:00

Coffee break (30’) – EMA info points

Session II: Availability of veterinary medicines 16:30

Chair: Fia Westerholm (EMA)

Vaccine availability: -

Action plan (20’)

Faye Ioannou (EMA)

-

Industry perspective (action plan and progress following 2015 workshop) (20’)

Frédéric Descamps (Zoetis/IFAH-Europe)

17:10

Impact of future legislation on availability (20’) Pablo Hervas (Veterindustria/IFAH-Europe)

17:50

Questions (20’)

18:00

Cocktail reception at The Pearson Room Restaurant, followed by walking buffet from 18:45

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5505 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Friday 17th March 2017 Session III: Innovation 09:00

Chair: Roxane Feller (IFAH-Europe)

Horizon scanning: General outcome from meetings with industry; Early support for novel types of products (15’) Fia Westerholm (EMA)

09:15

Innovation: How to make legislation more supportive for innovation (15’) Peter Oostenbach (MSD/IFAH-Europe)

09:30

Update on ADVENT and progress on Q&A documents: experience with predrafting consultations (10’) Minna Leppänen (EMA)

09:40

Questions (15’)

Session IV: EU Procedural updates 09:55

Chair: Melanie Leivers (EMA)

Recent experiences with centralised procedure: opportunities for development (10’) Teresa Potter (EMA)

10:05

Best practice guide on adherence to timetables: status update (15’) Piotr Kozarewicz (EMA)

10:20

Questions (15’)

10.35

EMA procedural updates (15’) Emily Drury (EMA)

10:50

Questions (15’)

11:05

Coffee break (30’) – EMA info points

Session V: Regulatory policy 11:35

Future Legislation: harmonisation of SPCs: -

Industry viewpoint (15’)

Emmanuelle Royer (Caroline Toulemonde) (Merial/IFAH-Europe)

11:50

Questions (10’)

12:00

Future Legislation: pharmacovigilance:

12:40

Chair: David Mackay (EMA)

-

Pharmacovigilance and product data (20’)

-

Industry Vision (20’)

Jos Olaerts (EMA)

Tony Simon (Zoetis/IFAH-Europe)

Questions (10’)

Close of the meeting (5’)

2017 EMA Veterinary Medicines Info Day Organised in collaboration with IFAH-Europe EMA/595779/2016

Fia Westerholm (EMA); Rick Clayton (IFAH-Europe)

Page 2/2

Agenda - European Medicines Agency veterinary medicines info day

Send a question via our website www.ema.europa.eu/contact. © European Medicines ... Innovation: How to make legislation more supportive for innovation (15').

93KB Sizes 7 Downloads 257 Views

Recommend Documents

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

Agenda - European Medicines Agency - Europa EU
Dec 7, 2016 - publication of clinical data (Policy 0070) and revisions to the guidance to industry – Industry Associations Webinar. 9 December 2016, 10:00 to ...

Veterinary pharmacovigilance 2016 - European Medicines Agency
Feb 16, 2017 - monitoring of several centrally authorised products ..... regulatory tools within the EU that are ... Following to this, a Rapid alert was circulated.

Agenda - European Medicines Agency - Europa EU
Sep 19, 2017 - 14:00-14:05. 2. Data integrity – early signal detection. - data patterns/trends in data ... 16:20-17:00. 5. Inspections of Ligand Binding Assays (in.

Agenda - European Medicines Agency - Europa EU
Nov 7, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone ...... Visualisation of choline metabolism in malignant neoplasms ..... A paediatric investigation plan (PIP) is a dev

Agenda - European Medicines Agency - Europa EU
Jan 23, 2018 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be

Agenda - European Medicines Agency - Europa EU
Oct 24, 2017 - Application of Article 8(2) of the Orphan Regulation ..... propoxy)-phenyl]-methanone, EMA/OD/187/14 Herpes simplex type 1 virus containing.

Agenda - European Medicines Agency - Europa EU
Jun 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... EMA initiatives to support and accelerate early access. 10:00 2.1 ...

Agenda - Patient Registries Workshop - European Medicines Agency
Oct 18, 2016 - Send a question via our website www.ema.europa.eu/contact ... marketing authorisation holder (MAH) to create a new registry based on a ...

Agenda - European Medicines Agency - Europa EU
6 days ago - EMA/OD/103/14 Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment, EMA/OD/175/14 Allogeneic ...

Agenda - European Medicines Agency - Europa EU
o Pilot to test draft model ... Endorsement of Enpr-EMA membership criteria Mark Turner/Irmgard. Eichler ... Endorsement of newly received applications.